Medical Care

Global RNAi Therapy Market Research Report 2025

The global market for RNAi Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
RNAi Therapy is a new treatment method that uses RNA interference (RNA interference, RNAi) to treat diseases. RNA interference refers to the introduction of double-stranded RNA molecules, so that the mRNA molecules of a specific gene cannot be translated into proteins, thereby achieving the purpose of inhibiting the expression of the gene. RNAi therapy utilizes the human body"s own gene regulation mechanism. It has strong targeting, good therapeutic effect, and few side effects. It is a new type of treatment with great potential.
North American market for RNAi Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for RNAi Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for RNAi Therapy in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of RNAi Therapy include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence, Sirnaomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNAi Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Therapy.
The RNAi Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNAi Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics
Segment by Type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)
Segment by Application
Oncology
Cardiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule Interfering Ribonucleic Acid (SiRNA)
1.2.3 Microrna (MiRNA)
1.3 Market by Application
1.3.1 Global RNAi Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Therapy Market Perspective (2020-2031)
2.2 Global RNAi Therapy Growth Trends by Region
2.2.1 Global RNAi Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNAi Therapy Historic Market Size by Region (2020-2025)
2.2.3 RNAi Therapy Forecasted Market Size by Region (2026-2031)
2.3 RNAi Therapy Market Dynamics
2.3.1 RNAi Therapy Industry Trends
2.3.2 RNAi Therapy Market Drivers
2.3.3 RNAi Therapy Market Challenges
2.3.4 RNAi Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Therapy Players by Revenue
3.1.1 Global Top RNAi Therapy Players by Revenue (2020-2025)
3.1.2 Global RNAi Therapy Revenue Market Share by Players (2020-2025)
3.2 Global RNAi Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNAi Therapy Revenue
3.4 Global RNAi Therapy Market Concentration Ratio
3.4.1 Global RNAi Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Therapy Revenue in 2024
3.5 Global Key Players of RNAi Therapy Head office and Area Served
3.6 Global Key Players of RNAi Therapy, Product and Application
3.7 Global Key Players of RNAi Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Therapy Breakdown Data by Type
4.1 Global RNAi Therapy Historic Market Size by Type (2020-2025)
4.2 Global RNAi Therapy Forecasted Market Size by Type (2026-2031)
5 RNAi Therapy Breakdown Data by Application
5.1 Global RNAi Therapy Historic Market Size by Application (2020-2025)
5.2 Global RNAi Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNAi Therapy Market Size (2020-2031)
6.2 North America RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNAi Therapy Market Size by Country (2020-2025)
6.4 North America RNAi Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Therapy Market Size (2020-2031)
7.2 Europe RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNAi Therapy Market Size by Country (2020-2025)
7.4 Europe RNAi Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Therapy Market Size (2020-2031)
8.2 Asia-Pacific RNAi Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNAi Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific RNAi Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Therapy Market Size (2020-2031)
9.2 Latin America RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNAi Therapy Market Size by Country (2020-2025)
9.4 Latin America RNAi Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Therapy Market Size (2020-2031)
10.2 Middle East & Africa RNAi Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNAi Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa RNAi Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam
11.1.1 Alnylam Company Details
11.1.2 Alnylam Business Overview
11.1.3 Alnylam RNAi Therapy Introduction
11.1.4 Alnylam Revenue in RNAi Therapy Business (2020-2025)
11.1.5 Alnylam Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics RNAi Therapy Introduction
11.2.4 Sarepta Therapeutics Revenue in RNAi Therapy Business (2020-2025)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Details
11.3.2 Alnylam Pharmaceuticals Business Overview
11.3.3 Alnylam Pharmaceuticals RNAi Therapy Introduction
11.3.4 Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2020-2025)
11.3.5 Alnylam Pharmaceuticals Recent Development
11.4 Moderna
11.4.1 Moderna Company Details
11.4.2 Moderna Business Overview
11.4.3 Moderna RNAi Therapy Introduction
11.4.4 Moderna Revenue in RNAi Therapy Business (2020-2025)
11.4.5 Moderna Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi RNAi Therapy Introduction
11.5.4 Sanofi Revenue in RNAi Therapy Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Arcturus Therapeutics
11.6.1 Arcturus Therapeutics Company Details
11.6.2 Arcturus Therapeutics Business Overview
11.6.3 Arcturus Therapeutics RNAi Therapy Introduction
11.6.4 Arcturus Therapeutics Revenue in RNAi Therapy Business (2020-2025)
11.6.5 Arcturus Therapeutics Recent Development
11.7 Silence
11.7.1 Silence Company Details
11.7.2 Silence Business Overview
11.7.3 Silence RNAi Therapy Introduction
11.7.4 Silence Revenue in RNAi Therapy Business (2020-2025)
11.7.5 Silence Recent Development
11.8 Sirnaomics
11.8.1 Sirnaomics Company Details
11.8.2 Sirnaomics Business Overview
11.8.3 Sirnaomics RNAi Therapy Introduction
11.8.4 Sirnaomics Revenue in RNAi Therapy Business (2020-2025)
11.8.5 Sirnaomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNAi Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule Interfering Ribonucleic Acid (SiRNA)
Table 3. Key Players of Microrna (MiRNA)
Table 4. Global RNAi Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global RNAi Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global RNAi Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global RNAi Therapy Market Share by Region (2020-2025)
Table 8. Global RNAi Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global RNAi Therapy Market Share by Region (2026-2031)
Table 10. RNAi Therapy Market Trends
Table 11. RNAi Therapy Market Drivers
Table 12. RNAi Therapy Market Challenges
Table 13. RNAi Therapy Market Restraints
Table 14. Global RNAi Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global RNAi Therapy Market Share by Players (2020-2025)
Table 16. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2024)
Table 17. Ranking of Global Top RNAi Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by RNAi Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of RNAi Therapy, Headquarters and Area Served
Table 20. Global Key Players of RNAi Therapy, Product and Application
Table 21. Global Key Players of RNAi Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNAi Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global RNAi Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global RNAi Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global RNAi Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global RNAi Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global RNAi Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global RNAi Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global RNAi Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific RNAi Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific RNAi Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific RNAi Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa RNAi Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa RNAi Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Alnylam Company Details
Table 47. Alnylam Business Overview
Table 48. Alnylam RNAi Therapy Product
Table 49. Alnylam Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 50. Alnylam Recent Development
Table 51. Sarepta Therapeutics Company Details
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics RNAi Therapy Product
Table 54. Sarepta Therapeutics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 55. Sarepta Therapeutics Recent Development
Table 56. Alnylam Pharmaceuticals Company Details
Table 57. Alnylam Pharmaceuticals Business Overview
Table 58. Alnylam Pharmaceuticals RNAi Therapy Product
Table 59. Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 60. Alnylam Pharmaceuticals Recent Development
Table 61. Moderna Company Details
Table 62. Moderna Business Overview
Table 63. Moderna RNAi Therapy Product
Table 64. Moderna Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi RNAi Therapy Product
Table 69. Sanofi Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Arcturus Therapeutics Company Details
Table 72. Arcturus Therapeutics Business Overview
Table 73. Arcturus Therapeutics RNAi Therapy Product
Table 74. Arcturus Therapeutics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 75. Arcturus Therapeutics Recent Development
Table 76. Silence Company Details
Table 77. Silence Business Overview
Table 78. Silence RNAi Therapy Product
Table 79. Silence Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 80. Silence Recent Development
Table 81. Sirnaomics Company Details
Table 82. Sirnaomics Business Overview
Table 83. Sirnaomics RNAi Therapy Product
Table 84. Sirnaomics Revenue in RNAi Therapy Business (2020-2025) & (US$ Million)
Table 85. Sirnaomics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report


List of Figures
Figure 1. RNAi Therapy Picture
Figure 2. Global RNAi Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNAi Therapy Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Interfering Ribonucleic Acid (SiRNA) Features
Figure 5. Microrna (MiRNA) Features
Figure 6. Global RNAi Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global RNAi Therapy Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Cardiology Case Studies
Figure 10. Others Case Studies
Figure 11. RNAi Therapy Report Years Considered
Figure 12. Global RNAi Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global RNAi Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global RNAi Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global RNAi Therapy Market Share by Players in 2024
Figure 16. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by RNAi Therapy Revenue in 2024
Figure 18. North America RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America RNAi Therapy Market Share by Country (2020-2031)
Figure 20. United States RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe RNAi Therapy Market Share by Country (2020-2031)
Figure 24. Germany RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific RNAi Therapy Market Share by Region (2020-2031)
Figure 32. China RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America RNAi Therapy Market Share by Country (2020-2031)
Figure 40. Mexico RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa RNAi Therapy Market Share by Country (2020-2031)
Figure 44. Turkey RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE RNAi Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Alnylam Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 50. Moderna Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 52. Arcturus Therapeutics Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 53. Silence Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 54. Sirnaomics Revenue Growth Rate in RNAi Therapy Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies